I am honored to serve as a Director “Dow Institute for Advanced Biological & Animal Research”. DIABAR is a state-of-the-art facility meeting the international standards; it has four major sections ranging from preclinical toxicology testing facility to Research and Development (R&D) section extended to central animal house and a Basic Biological Manufacturing Facility (BBMF) for the translation of R&D projects. Quality control section helps abide by the international standards and guidelines for the production of biological products whereas all logistics and working in DIABAR are strictly regulated by its QMS. We are unique in the country in maintaining a diverse group of experimental animals and a wonderful equine system for the manufacturing of biological products.

Our passion for research facilitates the scientific community from different domains of the health sector; it empowered us to have thought leadership in addressing the health challenges being faced by the country during the worst economic crises. Establishment of the DIABAR is a great addition in the list of country’s most accomplished research and development institutions to deliver results on health and health-related Sustainable Development Goals. Over the past 20 years, we have leveraged our expertise in providing high-quality research and services for research students, academic institutions and other stakeholders in Health and pharmaceuticals.

DIABAR serves a hub of scientific activities; our Advanced Research Laboratory facilitates interdisciplinary research from vast avenues of academia and industry on the other hand Pre- Clinical Toxicological laboratory offers wide range of toxicity testing services using both in-vitro and in-vivo approaches, dedicated experimental animal models are also being used for precise results. We comply with FDA approved protocols and animal ethical guidelines for testing of drugs and natural extracts etc. Quality control section of DIABAR not only fulfills institutional needs rather it outsources its testing facilities. Through our work, we have established strong ties with the government and private sector across the country, and brides‟ strong collaborations with renowned institutions around the globe.

DIABAR also focuses on academia; we strongly encourage youngsters across the country to join us for collaborative research work and training. We also provide experimental 100 class facilities for animal surgical procedures to researchers and faculty members. We also support postgraduate students to carry out their experimental work with the provision of full resources.

Our vision is to strengthen the health and economic sector of the country by indigenous production of biopharmaceutical products including vaccines. Keeping in view the country’s needs, our major projects focus on the production of anti-snake venom against big 4 of Pakistan and manufacturing of inactivated rabies vaccine using local virus strains.

Being a Director of the institute; I constantly encourage and support the DIABAR team to work day and night, I‟m very delighted to follow our honorable Vice Chancellor, Prof. Dr. Muhammad Saeed Quraishy‟s Vision for the betterment of our health system and my self- commitment is to keep serving for the national cause. I‟m quite hopeful to meet the strategic plans of Dow University of Health Sciences by bringing up the quality products at national level as a Basic Biological Manufacturer. We want to bring up the facility as an International Accredited Laboratory with licensing to work as Pre-clinical & Toxicological research and screening service provider using animal models etc., for all this up gradation and to meet aforementioned milestones DUHS has been continuously supporting us to build the infrastructure. Read more